Trial Information

New York Prevention Care Manager Project / Medicaid Managed Care Organization Version

OBJECTIVES:

Primary

- Develop and evaluate an enhanced telephone support intervention (Prevention Care
Manager [PCM]) to promote colorectal, cervical, and breast cancer screening more widely
among women enrolled in a Medicaid Managed Care Organization (MMCO).

- Explore the impact of patient, Community/Migrant Health Center (C/MHC), and MMCO
characteristics on cancer screening status and the impact of the intervention.

- Evaluate the impact of the enhanced PCM intervention upon colorectal, breast, and
cervical cancer screening rates.

Secondary

- Compare the status of women who are up-to-date (UTD) on CRC screening versus the UTD
status of cervical cancer and breast cancer screening.

OUTLINE: This is a randomized, controlled study. The study is conducted in 2 parts.

- Part 1 (barrier interview and pilot testing): Patients are stratified according to
primary language and whether or not they have had an outpatient visit in the past year.

- Barrier interview: Patients undergo a 15-30 minute interview to determine barriers
they face preventing them from receiving recommended cancer screenings and
healthcare, as well as facilitators which have encouraged them to be screened.

- Pilot testing: Patients from the barrier interviews and other eligible Medicaid
Managed Care Organization (MMCO) patients receive scripted telephone calls from a
Prevention Care Manager to assist them in getting up-to-date on their cancer
screening tests over 3 months.

- Part 2 (randomized control trial): Patients are stratified according to treatment
center (Community/Migrant health center vs Diagnostic and Treatment Center) and age.
Patient are randomized to 1 of 2 intervention arms.

- Arm I (Prevention Care Manager): Patients are stratified according to the number
of tests for which they are up-to-date at baseline. Patients receive reminder
letters encouraging them to contact their primary care provider for colorectal,
breast, and cervical cancer screening and 3 to 4 telephone support calls to help
them become up to date for colorectal, breast, and cervical cancer screening.

- Arm II (usual care): Patients receive usual care according to their primary care
physician.

In both arms, patients are followed for 18 months.

PROJECTED ACCRUAL: A total of 2,600 patients will be accrued for this study.